ALKS(Alkermes plc) 的内部人交易:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,035 | $46.17 |
| 2026-10-02 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $41.03 |
| 2026-09-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $48.01 |
| 2026-09-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 9,000 | $46.99 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | 公开市场卖出 | 664 | $49.65 |
| 2026-08-17 | Nichols Christian Todd | SVP, Chief Commercial Officer | 公开市场卖出 | 6,912 | $49.19 |
| 2026-08-03 | snyderman nancy lynn MD | 董事 | 公开市场卖出 | 44,472 | $50.35 |
| 2026-08-03 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 9,000 | $48.58 |
| 2026-08-03 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $48.58 |
| 2026-07-06 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $54.03 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 700 | $52.13 |
| 2026-07-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 8,300 | $51.46 |
| 2026-06-12 | Wright Christopher I | 董事 | 公开市场卖出 | 2,000 | $45.10 |
| 2026-06-04 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $43.05 |
| 2026-06-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 9,000 | $41.67 |
| 2026-05-29 | Parisi Samuel Joseph | VP, Finance (Interim PAO) | 公开市场卖出 | 16,217 | $42.36 |
| 2026-05-04 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $33.20 |
| 2026-05-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 9,000 | $33.40 |
| 2026-04-06 | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 公开市场卖出 | 2,034 | $34.57 |
| 2026-04-01 | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 公开市场卖出 | 9,000 | $35.51 |